An autologous antigen-agnostic dendritic cell therapy that forgoes antigen loading
2024
Abstract
We developed a method for generating dendritic cell progenitors (DCPs) from hematopoietic stem and progenitor cells isolated from bone marrow or blood. When engineered to express IL-12 and FLT3L, these DCPs reprogram the tumor microenvironment and elicit anti-tumor immunity without the need for ex vivo antigen loading.
Details
Title
An autologous antigen-agnostic dendritic cell therapy that forgoes antigen loading
Author(s)
De Palma, Michele
Published in
Nature Cancer
Date
2024-01-03
Publisher
Nature Portfolio, Berlin
ISSN
2662-1347
Other identifier(s)
View record in Web of Science
Laboratories
UPDEPALMA
Record Appears in
Scientific production and competences > SV - School of Life Sciences > ISREC - Swiss Institute for Experimental Cancer Research > UPDEPALMA - Prof. De Palma Group
Peer-reviewed publications
Work produced at EPFL
Journal Articles
Published
Peer-reviewed publications
Work produced at EPFL
Journal Articles
Published
Grant
EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
Record creation date
2024-02-21